<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: bulgaria</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'bulgaria'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22bulgaria%22&t=%22bulgaria%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 03:00:34 +0100</lastBuildDate>
        <item>
            <title>Hepatitis A in Bulgaria</title>
            <link>http://www.medworm.com/index.php?rid=5161737&amp;cid=t_171968_10_f&amp;fid=35345&amp;url=http%3A%2F%2Fwww.GIDEONonline.com%2F2011%2F08%2F25%2Fhepatitis-a-in-bulgaria%2F</link>
            <description>The incidence of viral hepatitis in Bulgaria has actually decreased in recent years [1-3]  See graph: 
 Nevertheless, disease rates in Bulgaria remain slightly higher than those in neighboring countries.
 

Graphs are generated using an interactive online system &amp;#8211; see GIDEON Graphs
References:
1. Berger SA. Infectious Diseases of Bulgaria, 2011. 68 pp, 101 graphs, 967 references. Gideon e-books, http://www.gideononline.com/ebooks/country/infectious-diseases-of-bulgaria/
2. Berger SA. Hepatitis A: Global Status, 2011. 163 pp, 180 graphs, 1073 references. Gideon e-books, http://www.gideononline.com/ebooks/disease/hepatitis-a-global-status/
3. Berger SA. Hepatitis B: Global Status, 2011. 327 pp, 405 graphs, 1517 references. Gideon e-books, http://www.gideononline.com/ebooks/disease/hepa...</description>
            <author>GIDEON blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5161737</comments>
            <pubDate>Fri, 26 Aug 2011 06:03:23 +0100</pubDate>
            <guid isPermaLink="false">5161737</guid>        </item>
        <item>
            <title>A Small Step Back For MannKind?</title>
            <link>http://www.medworm.com/index.php?rid=4139478&amp;cid=t_171968_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F8b4V5ZDEQ4A%2F</link>
            <description>John Arditi has created quite a stir. The former senior director for worldwide regulatory affairs at MannKind recently filed a wrongful termination lawsuit against the drugmaker for allegedly retaliating against him after he insisted on reporting to the FDA what he believed was misconduct at clinical trial sites in Russia and Bulgaria (back story).
After the news broke, MannKind released a statement saying an independent investigator was hired to review the data, which is being gathered to support approval for the Afrezza inhaled insulin device, and that &amp;#8220;there was no evidence of any deception or intent on the part of MannKind to deceive the FDA.&amp;#8221; That leaves open the question as to whether Arditi spotted real fraud, although cfo Matt Pfeffer is quoted as saying the claims have...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4139478</comments>
            <pubDate>Fri, 05 Nov 2010 15:32:21 +0100</pubDate>
            <guid isPermaLink="false">4139478</guid>        </item>
        <item>
            <title>Former MannKind Exec Charges Clinical Trial Fraud</title>
            <link>http://www.medworm.com/index.php?rid=4134253&amp;cid=t_171968_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FQOHWDa0KH9k%2F</link>
            <description>Will this be a big step back for MannKind? A former MannKind exec has filed a lawsuit charging the drugmaker fired him in retaliation for alleging that scientific misconduct involving clinical trial data for the fledgling Afrezza diabetes drug was withheld from the FDA. The charges, which concern clinical trial sites in Russia and Bulgaria, were made by John Artidi, a former senior director for regulatory affairs, TheStreet writes.
In the lawsuit, which was filed in a New Jersey state court two months ago, Arditi claimed he uncovered evidence of potential scientific misconduct at the sites and informed MannKind execs. At a site in Russia, for instance, he charged patients enrolled in the study had the same blood pressure readings at each visit for several months, but and so the finding cou...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4134253</comments>
            <pubDate>Thu, 04 Nov 2010 22:05:33 +0100</pubDate>
            <guid isPermaLink="false">4134253</guid>        </item>
        <item>
            <title>The Laffer Curve Strikes Again</title>
            <link>http://www.medworm.com/index.php?rid=3914985&amp;cid=t_171968_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F-RvwrsYCk8s%2F</link>
            <description>By Daniel J. MitchellIn the private sector, no business owner would be dumb enough to assume that higher prices automatically translate into proportionately higher revenues. If McDonald&amp;#8217;s boosted hamburger prices by 30 percent, for instance, the experts at the company would fully expect that sales would decline. Depending on the magnitude of the drop, total revenue might still climb, but by far less than 30 percent. And it&amp;#8217;s quite possible that the company would lose revenue. In the public sector, however, there is very little understanding of how the real world works. Here&amp;#8217;s a Reuters story I saw on Tim Worstall&amp;#8217;s blog, which reveals that Bulgaria and Romania both are losing revenue after increasing tobacco taxes.
Cash-strapped Bulgaria and Romania hoped taxing cig...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3914985</comments>
            <pubDate>Mon, 30 Aug 2010 11:12:16 +0100</pubDate>
            <guid isPermaLink="false">3914985</guid>        </item>
        <item>
            <title>Making a Little Big Difference</title>
            <link>http://www.medworm.com/index.php?rid=1268449&amp;cid=t_171968_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F243216403%2F</link>
            <description>I was talking to two of my students yesterday about classes for next year, their majors, scholarships and fellowships. Both had looked at websites for scholarships, and read the biographies of the winners, of college students who, while maintaining the highest GPAs, playing varsity sports, and conducting research in molecular biology, create medical clinics in foreign countries, develop plans for peace between various warring nations, play first violin in the orchestra, write poetry, serve as the editor for the campus newspaper and win the prize for best thesis&amp;#8230;&amp;#8230;
&amp;#8220;How does anyone do all that, Dr. Chew?&amp;#8221; my students asked me, pointing out that they could hardly go for a year to an &amp;#8220;underdeveloped nation&amp;#8221; and teach English in an orphanage: Most of my stude...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1268449</comments>
            <pubDate>Fri, 29 Feb 2008 09:16:06 +0100</pubDate>
            <guid isPermaLink="false">1268449</guid>        </item>
    </channel>
</rss>

